Dieter Schmoll

Title: The Innovative Contributions of Dieter Schmoll

Introduction

Dieter Schmoll is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of six patents to his name, Schmoll's work focuses on the development of compounds that address various health issues.

Latest Patents

Among his latest patents are two key inventions related to heterocyclic compounds. The first patent involves heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and their use. These compounds are designed to treat conditions such as metabolic syndrome, insulin resistance, obesity, and diabetes. The second patent focuses on phenothiazine derivatives with a double bond, detailing methods for their production and their application as pharmaceuticals. These substituted phenothiazines are also accompanied by physiologically acceptable salts, enhancing their medicinal properties.

Career Highlights

Dieter Schmoll has had a distinguished career, working with prominent companies in the pharmaceutical industry. He has been associated with Sanofi-Aventis Deutschland GmbH and Sanofi-Aventis, where he contributed to various research and development projects. His expertise in medicinal chemistry has been instrumental in advancing the understanding and treatment of complex health conditions.

Collaborations

Throughout his career, Schmoll has collaborated with several professionals in the field. Notable coworkers include Elisabeth Defossa and Dieter Kadereit, who have worked alongside him on various projects, contributing to the success of his inventions.

Conclusion

Dieter Schmoll's innovative work in the field of medicinal chemistry has led to the development of important compounds that hold promise for treating significant health issues. His contributions continue to impact the pharmaceutical industry positively.